Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NanoString Technologies Inc (NASDAQ:NSTG)

19.05
Delayed Data
As of Sep 26
 -0.21 / -1.09%
Today’s Change
11.30
Today|||52-Week Range
19.88
+29.50%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$382.0M

Company Description

NanoString Technologies, Inc. develops, manufactures and sells robust, intuitive products that unlock scientifically valuable and clinically actionable genomic information from minute amounts of tissue. The company operates through one segment which is the development, manufacture and commercialization of instruments, consumables and services. NanoString Technologies was founded by Amber Ratcliffe, Krassen Dimitrov and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.

Contact Information

NanoString Technologies, Inc.
530 Fairview Avenue North
Seattle Washington 98109
P:(206) 378-6266
Investor Relations:

Employees

Shareholders

Other institutional49.06%
Individual stakeholders32.69%
Mutual fund holders13.10%

Top Executives

Robert Bradley GrayPresident, Chief Executive Officer & Director
Wayne D. BurnsSenior Vice President-Operations & Administration
James Algot JohnsonChief Financial Officer
Joseph M. BeechemSenior Vice President-Research & Development
Alessandra CesanoChief Medical Officer